identifies themes and clusters of stock market movements
Market Real TimeHistorical AnalysisClick here for daily refresh schedule
Robotic Surgery$131.86
-2.30%4:00PM 10/19/2020
The global market for surgical robots is forecast to grow to $24 billion by 2025, according to a new report by Global Market Insights.

Aggregated price index

Aggregated price index with volume information


  • Robotic Surgery stocks down 2.3% on average while median return down 2.2% in a day
  • Robotic Surgery stocks down 2.1% on average while median return down 2.6% in a week
  • Robotic Surgery stocks up 34.8% on average while median return up 0.6% in a month
  • When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.

Aggregated price index is based on equal weighted constituencies returns,Aggregated volume information is based on sum of all constituencies volumes

Index Constituencies

Related Stocks

Related ETFs

leak data

  • 1M winners are : Winners for past month are $APM 55.3%, $ISRG 8.1%
  • 1M losers are : Losers for past month are $MBOT -0.8%, $STXS -9.5%
  • 1W winners are : Winners for past week are
  • 1W losers are : Losers for past week are $STXS -3.0%, $APM -4.7%
Pick two stocks to compare:

Correlation Analysis

Index correlation analysis

Correlation for the past month is 21.9%, for the past 3 months is 13.8%

In the past month for a 5 days rolling window, the highest corrrelation is 66.9%, the lowest correlation is -15.6%, the latest correlation is -5.0%

When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.

Among pairwise correlation, the highest correlation is 59.8% between ISRG and STXS

The lowest correlation is -12.7% between APM and MDT

Stock news

    Got $5,000? These Stocks Should Be Surefire Winners Over the Next Decade

    In 20 years, Intuitive Surgical has installed 5,764 of its da Vinci surgical systems worldwide. The company has locked in its existing customers for the long haul and remains the clear go-to for robotic-assistive surgical systems. Early on, Intuitive Surgical's revenue primarily came from its pricey systems.

    First Hospitals in the World Adopt Genesis Robotic Technology for Cardiac Heart Rhythm Disorders

    ST. LOUIS, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced it has completed installations of the world’s first Genesis Robotic Magnetic Navigation (RMN) systems to treat heart rhythm disorders at Helsinki University Hospital in Finland and Banner - University Medicine Heart Institute in Phoenix, Arizona. “The clinical benefits of robotics in electrophysiology have been ext...

    Stereotaxis CEO Invited to Speak on Plenary Panel at RAPS Convergence 2020

    ST. LOUIS, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and CEO, will serve as a panel speaker at the plenary session of RAPS Convergence 2020. RAPS Convergence is the largest annual gathering of regulatory professionals in healthcare and is hosted by the Regulatory Affairs Professionals Society. The plenary session will take place on Sunday,...

    Why Intuitive Surgical Stock Popped Today

    Shares of robotic surgery specialist Intuitive Surgical (NASDAQ: ISRG) are getting a lift in Wednesday trading -- up 3.4% in the day's final half hour -- and from a rather unexpected source. This morning, analysts at R.W. Baird initiated coverage of Intuitive Surgical stock with a neutral rating and a $700 price target. In mid-August, reports, investment banker SVB Leerink also issued a report on Intuitive.

    10 Long-Term Stocks to Buy to Profit From Secular Trends

    When it comes to betting on long-term stocks set to benefit from the novel coronavirus acceleration of secular trends preceding the pandemic, the most obvious plays are in digital technology.Academic research papers are being churned out to explain just how Covid-19 has changed the world of business permanently. Some industries and sectors have fared much better than others during the crisis.Amazon (NASDAQ:AMZN) is just one example of a company that's benefited from Covid-19, with higher e-c...

    Stereotaxis to Present at Three Investor Conferences in September

    ST. LOUIS, Aug. 28, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that David Fischel, Chairman and CEO, will present at three investor conferences in September 2020. * LD Micro 500 Virtual Conference Mr. Fischel will present an overview of Stereotaxis business on Friday, September 4, 2020, 9:00 - 9:20 am EST and will be available that day for one-on-one meetings. * Cantor Fitz...

    Does Wall Street Prefer Medtronic Or Intuitive Surgical Amid The Covid Crisis?

    Medical device makers are facing challenging times as elective surgeries have either been cancelled or postponed with hospitals and healthcare facilities shifting their entire focus toward addressing the COVID-19 pandemic.In May, the CovidSurg Collaborative estimated that about 28.4 million elective surgeries could be cancelled or postponed globally in 2020 due to COVID-19. However, the easing of lockdowns and social distancing restrictions is driving the recovery of medical device makers’ sales...

    Intuitive Surgical Is Adding Onto A Recent Breakout — Is ISRG Stock A Buy?

    ISRG stock is on the rise this year, but Intuitive Surgical stock performance is lagging its peers in its medical technology group. So, is it time to take on this robotic surgery stock?

    Journal of American College of Cardiology Publishes Pioneering Study Using Stereotaxis Robotic Technology to Treat Pulmonary Hypertension

    ST. LOUIS, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced a pioneering publication in the prestigious Journal of the American College of Cardiology (JACC) on the use of Stereotaxis’ robotic technology to treat pulmonary hypertension. Dr. Alexander Romanov and colleagues at the National Medical Research Center in Novosibirsk, Russia led an investigator-initiated 50-patient,...

    Microbot Medical Schedules Virtual Meeting to Address Increased Interest Following its Recent Announcement

    Webinar to be Held on Wednesday August 26th at 11am ETHINGHAM, Mass., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Following its participation at the Needham Virtual Med Tech & Diagnostic conference, as well as the overwhelming interest generated since its recent announcement which included the outcome of a feasibility animal study with respect to the LIBERTYTM Robotic System, Microbot Medical Inc. (Nasdaq: MBOT) will host a webinar on Wednesday, August 26, 2020 at 11:00am ET.  Harel Gadot, the Company’s C...